Display options
Cite
Veal GJ, Tweddle DA, Visser J, et al. Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-. Cancers (Basel). 2021;13(8)doi: 10.3390/cancers13081868.
Veal, G. J., Tweddle, D. A., Visser, J., Errington, J., Buck, H., Marange, J., Moss, J., Joseph, S., & Mulla, H. (2021). Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-. Cancers, 13(8), . https://doi.org/10.3390/cancers13081868
Veal, Gareth J, et al. "Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-." Cancers vol. 13,8 (2021). doi: https://doi.org/10.3390/cancers13081868
Veal GJ, Tweddle DA, Visser J, Errington J, Buck H, Marange J, Moss J, Joseph S, Mulla H. Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-. Cancers (Basel). 2021 Apr 14;13(8). doi: 10.3390/cancers13081868. PMID: 33919763; PMCID: PMC8070696.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2021 Apr 14;13(8). doi: 10.3390/cancers13081868.

Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-.

Cancers

Gareth J Veal, Deborah A Tweddle, Johannes Visser, Julie Errington, Helen Buck, Josephine Marange, Jon Moss, Shiju Joseph, Hussain Mulla

Affiliations

  1. Newcastle University Centre for Cancer, Translational & Clinical Research Institute Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  2. Great North Children's Hospital, Newcastle upon Tyne NE1 4LP, UK.
  3. Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  4. ClinPsy Limited, St. Albans, Hertfordshire AL3 5HN, UK.
  5. Nova Laboratories Limited, Leicester LE18 4YL, UK.
  6. BAST Inc Limited, Loughborough Innovation Centre, Loughborough LE11 3AQ, UK.
  7. Department of Pharmacy, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK.

PMID: 33919763 PMCID: PMC8070696 DOI: 10.3390/cancers13081868

Abstract

(1) Background: 13-

Keywords: 13-CRA; liquid; neuroblastoma; pharmacokinetics

References

  1. CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):3-10 - PubMed
  2. Clin Cancer Res. 2013 Jan 15;19(2):469-79 - PubMed
  3. Cancer Lett. 2003 Jul 18;197(1-2):185-92 - PubMed
  4. Clin Pharmacokinet. 2008;47(8):487-513 - PubMed
  5. J Oncol Pharm Pract. 2016 Jun;22(3):387-95 - PubMed
  6. Cancer Res. 1982 May;42(5):2087-91 - PubMed
  7. Med Pediatr Oncol. 1992;20(4):307-11 - PubMed
  8. Arch Dis Child. 2016 Jul;101(7):662-9 - PubMed
  9. AAPS J. 2011 Jun;13(2):143-51 - PubMed
  10. Cancer Chemother Pharmacol. 2016 Oct;78(4):763-8 - PubMed
  11. Br J Cancer. 2007 Mar 12;96(5):725-31 - PubMed
  12. Fundam Clin Pharmacol. 2008 Dec;22(6):605-8 - PubMed
  13. Cancer Chemother Pharmacol. 1996;39(1-2):34-41 - PubMed
  14. Br J Cancer. 2007 Feb 12;96(3):424-31 - PubMed
  15. Ther Drug Monit. 2011 Dec;33(6):711-8 - PubMed
  16. J Clin Oncol. 2009 Mar 1;27(7):1007-13 - PubMed
  17. Nat Rev Dis Primers. 2016 Nov 10;2:16078 - PubMed

Publication Types

Grant support